Abstract | INTRODUCTION: MATERIALS AND METHODS: RESULTS:
PROCR haplotype distribution was similar among groups of patients and controls. PROCR H1 and H3 haplotypes were less prevalent in antiphospholipid syndrome patients with arterial thrombosis than those without arterial thrombosis, but statistical significance was only reached for the H1 haplotype (58.0% vs. 85.7%, p = 0.003; odds ratio: 0.23 [95% CI 0.08-0.65]). No relationship between the PROCR H1 and H3 haplotypes and venous thrombosis was found. sEPCR levels were higher in H3 than in H1 carriers (175.5 [95% CI 60.9-290.1] ng/ml vs. 69.1 [95% CI 61.5-76.9] ng/ml, p < 0.01). No relationship of sEPCR with arterial or venous thrombosis was found. CONCLUSION: The PROCR H1 haplotype was less frequently found in APS patients with arterial thrombosis, suggesting a protective effect of PROCR H1 against arterial thrombosis in these patients. No relationship between sEPCR and thrombosis was found.
|
Authors | Miguel Angel Plasín-Rodríguez, Ignasi Rodríguez-Pintó, Patricia Patricio, Joan Monteagudo, Ricard Cervera, Joan Carles Reverter, Gerard Espinosa, Dolors Tàssies |
Journal | Thrombosis research
(Thromb Res)
Vol. 169
Pg. 128-134
(09 2018)
ISSN: 1879-2472 [Electronic] United States |
PMID | 30048851
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018 Elsevier Ltd. All rights reserved. |
Chemical References |
- Endothelial Protein C Receptor
- PROCR protein, human
|
Topics |
- Adult
- Antiphospholipid Syndrome
(complications, genetics)
- Endothelial Protein C Receptor
(genetics)
- Female
- Haplotypes
- Humans
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Protective Factors
- Thrombosis
(etiology, genetics)
|